Trump administration unveils up to 100% tariff on branded drugs
Drugmakers or nations that strike pricing deals or make U.S. manufacturing investment commitments can secure lower levies, or be spared them entirely, write Gavin Bade and Xavier Martinez, The Wall Street Journal.